These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 19623680)

  • 1. Changing pattern in the prescription of biological treatment in rheumatoid arthritis. A 7-year follow-up of 1839 patients in southern Sweden.
    Söderlin MK; Geborek P
    Ann Rheum Dis; 2008 Jan; 67(1):37-42. PubMed ID: 19623680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A more active treatment has profound effects on the health status of rheumatoid arthritis (RA) patients: results from a population-based RA register in Malmö, Sweden, 1997-2005.
    Söderlin MK; Lindroth Y; Turesson C; Jacobsson LT
    Scand J Rheumatol; 2010 May; 39(3):206-11. PubMed ID: 20001765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences in longitudinal disease and treatment characteristics of patients with rheumatoid arthritis replying and not replying to a postal questionnaire. Experience from a biologics register in southern Sweden.
    Söderlin MK; Jacobsson LT; Petersson IF; Englund M; Saxne T; Geborek P
    J Rheumatol; 2009 Jun; 36(6):1166-9. PubMed ID: 19411397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Wide difference in biologics usage and expenditure for the treatment of patients with rheumatoid arthritis in each prefecture in Japan analyzed using "National Database of Health Insurance Claims and Specific Health Checkups of Japan".
    Kamata Y; Minota S
    Rheumatol Int; 2018 Apr; 38(4):663-668. PubMed ID: 29204683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Costs and outcomes for patients with rheumatoid arthritis treated with biological drugs in Sweden: a model based on registry data.
    Kobelt G; Lindgren P; Geborek P
    Scand J Rheumatol; 2009; 38(6):409-18. PubMed ID: 19922015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Which patients with rheumatoid arthritis, spondyloarthritis, or juvenile idiopathic arthritis receive TNF-α antagonists in France? The CORPUS cohort study.
    Saraux A; Benichou J; Guillevin L; Idbrik L; Job-Deslandre C; Sibilia J; Soudant M; Wendling D; Guillemin F
    Clin Exp Rheumatol; 2015; 33(5):602-10. PubMed ID: 26315585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug adherence, response and predictors thereof for tocilizumab in patients with rheumatoid arthritis: results from the Swedish biologics register.
    Forsblad-d'Elia H; Bengtsson K; Kristensen LE; Jacobsson LT
    Rheumatology (Oxford); 2015 Jul; 54(7):1186-93. PubMed ID: 25505001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EQ-5D utility, response and drug survival in rheumatoid arthritis patients on biologic monotherapy: A prospective observational study of patients registered in the south Swedish SSATG registry.
    Jørgensen TS; Turesson C; Kapetanovic M; Englund M; Turkiewicz A; Christensen R; Bliddal H; Geborek P; Kristensen LE
    PLoS One; 2017; 12(2):e0169946. PubMed ID: 28151971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Individual variations in treatment decisions by Swedish rheumatologists regarding biological drugs for rheumatoid arthritis.
    Kalkan A; Hallert E; Carlsson P; Roback K; Sjöwall C
    Scand J Rheumatol; 2015; 44(4):265-70. PubMed ID: 26202443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physician Preferences and Variations in Prescription of Biologic Drugs for Rheumatoid Arthritis: A Register-Based Study of 4,010 Patients in Sweden.
    Kalkan A; Husberg M; Hallert E; Roback K; Thyberg I; Skogh T; Carlsson P
    Arthritis Care Res (Hoboken); 2015 Dec; 67(12):1679-85. PubMed ID: 26097219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors influencing rheumatologists' prescription of biological treatment in rheumatoid arthritis: an interview study.
    Kalkan A; Roback K; Hallert E; Carlsson P
    Implement Sci; 2014 Oct; 9():153. PubMed ID: 25304517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Biologics and mycobacterial diseases].
    Tsuyuguchi K; Matsumoto T
    Kekkaku; 2013 Mar; 88(3):337-53. PubMed ID: 23672175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination of disease-modifying antirheumatic drugs in the treatment of rheumatoid arthritis. A survey of Alabama rheumatologists.
    Baum SK; Tracy IC; Henderson EH; Alarcón GS
    Arthritis Care Res; 1991 Mar; 4(1):48-51. PubMed ID: 11188587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and incidence of rheumatoid arthritis in southern Sweden 2008 and their relation to prescribed biologics.
    Englund M; Jöud A; Geborek P; Felson DT; Jacobsson LT; Petersson IF
    Rheumatology (Oxford); 2010 Aug; 49(8):1563-9. PubMed ID: 20444855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variability in the prescription of biological drugs in rheumatoid arthritis in Spain: a multilevel analysis.
    López-Longo FJ; Seoane-Mato D; Martín-Martínez MA; Sánchez-Alonso F;
    Rheumatol Int; 2018 Apr; 38(4):589-598. PubMed ID: 29368023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors associated with physicians' prescriptions for rheumatoid arthritis drugs not filled by patients.
    Kan HJ; Dyagilev K; Schulam P; Saria S; Kharrazi H; Bodycombe D; Molta CT; Curtis JR
    Arthritis Res Ther; 2018 May; 20(1):79. PubMed ID: 29720237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Real-world utilization of DMARDs and biologics in rheumatoid arthritis: the RADIUS (Rheumatoid Arthritis Disease-Modifying Anti-Rheumatic Drug Intervention and Utilization Study) study.
    Gibofsky A; Palmer WR; Goldman JA; Lautzenheiser RL; Markenson JA; Weaver A; Schiff MH; Keystone EC; Paulus HE; Harrison MJ; Whitmore JB; Leff JA
    Curr Med Res Opin; 2006 Jan; 22(1):169-83. PubMed ID: 16393443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Higher education is associated with a better rheumatoid arthritis outcome concerning for pain and function but not disease activity: results from the EIRA cohort and Swedish rheumatology register.
    Jiang X; Sandberg ME; Saevarsdottir S; Klareskog L; Alfredsson L; Bengtsson C
    Arthritis Res Ther; 2015 Nov; 17():317. PubMed ID: 26546562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Medical treatment of rheumatoid arthritis in 2014 : Current data from the German Collaborative Arthritis Centers].
    Albrecht K; Huscher D; Eidner T; Kleinert S; Späthling-Mestekemper S; Bischoff S; Zink A
    Z Rheumatol; 2017 Feb; 76(1):50-57. PubMed ID: 27379740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of treatment initiation with tumor necrosis factor-α inhibitors in patients with rheumatoid arthritis.
    Desai RJ; Rao JK; Hansen RA; Fang G; Maciejewski ML; Farley JF
    J Manag Care Spec Pharm; 2014 Nov; 20(11):1110-20. PubMed ID: 25351972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.